
Retatrutide (30mg)
Retatrutide (30mg) is listed as a single-compound research material with a labelled amount of 30mg. The single-vial catalogue price is $179.99 USD.
SKU: PEP-019-30MG
COA ✓ · 99.682%Metabolic Research
SKU: PEP-007-10MG
Retatrutide (10mg) is listed as a single-compound research material with a labelled amount of 10mg. The single-vial catalogue price is $69.99 USD.
Quantity savings: 2–4 vials 5%, 5–9 vials 10%, 10+ vials 15%.
Other formats coming soon
View the product details and select the bell to express a format preference.
1 × $69.99$69.99
For laboratory research only. Not for human or veterinary use.
Retatrutide (10mg) is listed as a single-compound research material with a labelled amount of 10mg. The single-vial catalogue price is $69.99 USD.
The amount shown refers to the vial label. Compare other formats separately, including their price and documentation.
Store and handle according to the instructions provided for the supplied lot.
| Compound | Retatrutide (LY3437943) |
|---|---|
| CAS Number | 2381089-83-2 |
| Molecular Formula | C221H342N46O68 |
| Molecular Weight | 4731.3 g/mol |
| Sequence | 39-residue GIP/GLP-1/glucagon triple agonist with a C20 diacid lipid side chain |
| Category | Metabolic Research |
| Reported purity | 99.682% (CoA Reported) |
| Labelled amount | 10mg |
| Form | Lyophilized Powder |
| Storage | Consult the storage guidance supplied with the specific lot. |
Published batch report available.
Match the document’s sample, lot and labelled size. The document applies to its tested sample.
In Stock. Single-vial price: $69.99 USD.
Published batch report available. View documentation above.
For each available product: 2–4 vials receive 5% off, 5–9 receive 10% off and 10 or more receive 15% off, subject to the displayed quantity limit.
10mg identifies the amount on this vial’s label. It does not describe a concentration or a personal dose.